The European Commission (EC) Finally Approves Merck KGaA's Once-Failed MS Drug Cladribine Post author:Sam Post published:August 24, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Novartis Buys Rare Drug Voucher for $130M From Ultragenyx December 17, 2017 BridgeBio Launches QED Therapeutics With $65M and an Abandoned Novartis Cancer Program January 29, 2018 Acceleron Pharma Reports Fourth Quarter And Year Ended 2016 Operational And Financial Results February 28, 2017
BridgeBio Launches QED Therapeutics With $65M and an Abandoned Novartis Cancer Program January 29, 2018
Acceleron Pharma Reports Fourth Quarter And Year Ended 2016 Operational And Financial Results February 28, 2017